Peng Hui Chen
Director/Board Member chez VCREDIT HOLDINGS LIMITED
Profil
Peng Hui Chen founded NuProbe USA, Inc. Mr. Chen also currently works at CF PharmTech, Inc, as Director from 2020, VCREDIT Holdings Ltd., as Independent Non-Executive Director from 2018, Chengdu Bright Eye Hospital Co., Ltd., as Independent Director from 2019, and Qianglian Zhichuang (Beijing) Technology Co., Ltd., as Director.
Mr. Chen also formerly worked at China Everbright Holdings Co. Ltd., as Managing Director from 2011 to 2014, Jiangsu Yuyue Medical Equipment & Supply Co., Ltd., as Director from 2015 to 2017, Shangpharma Corp., as President, COO, CFO, Director & CAO from 2010 to 2011, BGI Genomics Co., Ltd., as Director, Hygeia Healthcare Holdings Co., Ltd., as Independent Non-Executive Director from 2019 to 2022, EIDP, Inc., as Manager-Business Development in 2006, Ligand Pharmaceuticals, Inc., as Principal, CITIC Capital Holdings Ltd., as Vice President, and Hongshan, as Partner.
Mr. Chen received his graduate degree in 1998 from Tulane University (Louisiana), undergraduate degree in 1993 from Nanjing University, and Masters Business Admin degree in 2003 from Kellogg School of Management.
Postes actifs de Peng Hui Chen
| Sociétés | Poste | Début |
|---|---|---|
| VCREDIT HOLDINGS LIMITED | Director/Board Member | 01/06/2018 |
| CHENGDU BRIGHT EYE HOSPITAL CO., LTD. | Director/Board Member | 20/09/2019 |
Qianglian Zhichuang (Beijing) Technology Co., Ltd.
 Qianglian Zhichuang (Beijing) Technology Co., Ltd. Hospital/Nursing ManagementHealth Services Qianglian Zhichuang (Beijing) Technology Co., Ltd. is a Chinese company that focuses on stroke diagnosis and treatment. The company is based in Beijing, China. The company offers integrated intelligent diagnosis and treatment services for bleeding and ischemic stroke. Qianglian Zhichuang® has developed a one-stop stroke intelligence diagnosis and treatment platform that covers prevention, screening, diagnosis, treatment, rehabilitation, and long-term follow-up. The company collaborates with leading domestic neural clinical centers, including Xuanwu Hospital, Huashan Hospital of Tiantan Hospital, and Changhai Hospital. Qianglian Zhichuang® has applied for dozens of national and provincial research topics and has applied for related fields of hundreds of domestic and international patents. The company was founded in 2016 by Lan Qin, Wen Zhe Liu. Wen Zhe Liu has been the CEO since 2016. | Director/Board Member | - |
CF PharmTech, Inc
 CF PharmTech, Inc Medical SpecialtiesHealth Technology CF PharmTech, Inc engages in the research, development, production and sale of respiratory diseases pharmaceutical products. It mainly involves in complex product & platform, innovative medicines, medical devices, & provide technical services. The company offers inhalers, asthma treatment products including Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray. CF PharmTech was founded by Li LI in 2007 and is headquartered in Suzhou, China. | Director/Board Member | 01/06/2020 |
Anciens postes connus de Peng Hui Chen
| Sociétés | Poste | Fin |
|---|---|---|
| HYGEIA HEALTHCARE HOLDINGS CO., LIMITED | Director/Board Member | 06/05/2022 |
| JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. | Director/Board Member | 01/11/2017 |
China Everbright Holdings Co. Ltd.
 China Everbright Holdings Co. Ltd. Investment Banks/BrokersFinance China Everbright Holdings Co. Ltd. provides investment banking, life insurance, and real estate development services. The private company is based in Beijing, China. The Chinese company is ultimately controlled by the Government of China. | Corporate Officer/Principal | 01/05/2014 |
| E I DU PONT DE NEMOURS AND CO | Corporate Officer/Principal | 01/01/2006 |
| LIGAND PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - |
Formation de Peng Hui Chen
| Tulane University (Louisiana) | Graduate Degree |
| Nanjing University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. | Health Technology |
| BGI GENOMICS CO., LTD. | Health Technology |
| VCREDIT HOLDINGS LIMITED | Finance |
| CHENGDU BRIGHT EYE HOSPITAL CO., LTD. | Health Services |
| HYGEIA HEALTHCARE HOLDINGS CO., LIMITED | Health Technology |
| Entreprise privées | 8 |
|---|---|
EIDP, Inc.
 EIDP, Inc. Chemicals: AgriculturalProcess Industries EIDP, Inc. engages in the provision of science-based products and services. It operates through the Seed and Crop Protection segments. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms around the world. The Crop Protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The company was founded by Eleuthere Irenee du Pont in 1802 and is headquartered in Indianapolis, IN. | Process Industries |
China Everbright Holdings Co. Ltd.
China Everbright Holdings Co. Ltd. Investment Banks/BrokersFinance China Everbright Holdings Co. Ltd. provides investment banking, life insurance, and real estate development services. The private company is based in Beijing, China. The Chinese company is ultimately controlled by the Government of China. | Finance |
CITIC Capital Holdings Ltd.
 CITIC Capital Holdings Ltd. Investment ManagersFinance CITIC Capital Holdings Ltd. engages in the provision of investment management and advisory services. Its businesses include private equity, real estate, structured investment and finance, asset management, and joint ventures. The company was founded by Yi Chen Zhang in 2002 and is headquartered in Hong Kong. | Finance |
Hongshan
 Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | Finance |
Shangpharma Corp.
 Shangpharma Corp. Pharmaceuticals: MajorHealth Technology Shangpharma Corp. provides pharmaceutical and biotechnology research outsourcing services. It offers various integrated services across the drug discovery and development process to international and chinese pharmaceutical and biotechnology companies, and academic and research institutions. The company was founded by Michael Xin Hui and Wenjuan Xiao in 2002 and is headquartered in Shanghai, China. | Health Technology |
CF PharmTech, Inc
CF PharmTech, Inc Medical SpecialtiesHealth Technology CF PharmTech, Inc engages in the research, development, production and sale of respiratory diseases pharmaceutical products. It mainly involves in complex product & platform, innovative medicines, medical devices, & provide technical services. The company offers inhalers, asthma treatment products including Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray. CF PharmTech was founded by Li LI in 2007 and is headquartered in Suzhou, China. | Health Technology |
NuProbe USA, Inc.
 NuProbe USA, Inc. Miscellaneous Commercial ServicesCommercial Services NuProbe USA, Inc. engages in the development of ultra-sensitive and multiplexed platform with reagents for non-invasive nucleic acid profiling and diagnostics. The firm offers VarTrace EGFR Assay, VarTrace BFAR Assay, and VarTrace AML multi-gene panel. The company was founded by Peng Yin, David Yu Zhang, and Victor Chenyang Shi in 2016 and is headquartered in Cambridge, MA. | Commercial Services |
Qianglian Zhichuang (Beijing) Technology Co., Ltd.
Qianglian Zhichuang (Beijing) Technology Co., Ltd. Hospital/Nursing ManagementHealth Services Qianglian Zhichuang (Beijing) Technology Co., Ltd. is a Chinese company that focuses on stroke diagnosis and treatment. The company is based in Beijing, China. The company offers integrated intelligent diagnosis and treatment services for bleeding and ischemic stroke. Qianglian Zhichuang® has developed a one-stop stroke intelligence diagnosis and treatment platform that covers prevention, screening, diagnosis, treatment, rehabilitation, and long-term follow-up. The company collaborates with leading domestic neural clinical centers, including Xuanwu Hospital, Huashan Hospital of Tiantan Hospital, and Changhai Hospital. Qianglian Zhichuang® has applied for dozens of national and provincial research topics and has applied for related fields of hundreds of domestic and international patents. The company was founded in 2016 by Lan Qin, Wen Zhe Liu. Wen Zhe Liu has been the CEO since 2016. | Health Services |
